Pharmacokinetics of letrozole and effects of its increasing doses on gonadotropins in ewes during the breeding season
- 3 November 2023
- journal article
- research article
- Published by Wiley in Journal of Veterinary Pharmacology and Therapeutics
- Vol. 47 (3) , 193-201
Abstract
Letrozole is a non‐steroidal, third‐generation aromatase inhibitor used in humans. Although letrozole is not approved for use in animals, it is used off‐label in cases of synchronization and infertility. The aim of this study was to determine the pharmacokinetics of letrozole after a single intravenous administration at three different doses in ewes during the breeding season and its effect on gonadotropins (luteinizing hormone (LH) and follicle‐stimulating hormone (FSH)) at the beginning of proestrus. The study was carried out on 24 healthy Merino ewes. Ewes were randomly divided into four groups (n = 6) as control, 0.5, 1, and 2 mg/kg. Plasma concentrations of letrozole were measured using HPLC‐UV and were analyzed by non‐compartmental analysis. LH and FSH concentrations were measured with a commercial ELISA kit. The terminal elimination half–life (t1/2ʎz) was significantly prolonged from 11.82 to 18.44 h in parallel with the dose increase. The dose‐normalized area under the concentration–time curve (AUC) increased, and total body clearance (ClT) decreased at the 1 and 2 mg/kg doses (0.05 L/h/kg) compared with the 0.5 mg/kg dose (0.08 L/h/kg). There were no differences in the volume of distribution at steady‐state and initial (C0.083h) plasma concentration values between dose groups. The decreased ClT, prolonged t1/2ʎz, and increased AUC at increasing doses showed the nonlinear kinetic behavior of letrozole. Letrozole significantly reduced LH concentration without affecting FSH concentration at all doses. As a result, letrozole has the potential to be used in synchronization methods and manipulation of the follicular waves due to its effect on LH secretion.Keywords
This publication has 36 references indexed in Scilit:
- Effects of a non-steroidal aromatase inhibitor on ovarian function in cattleReproduction, Fertility and Development, 2011
- Plasma Letrozole Concentrations in Postmenopausal Women With Breast Cancer Are Associated With CYP2A6 Genetic Variants, Body Mass Index, and AgeClinical Pharmacology & Therapeutics, 2011
- A bovine model for examining the effects of an aromatase inhibitor on ovarian function in womenFertility and Sterility, 2011
- Reproductive cycles in sheepAnimal Reproduction Science, 2011
- LetrozoleDrugs, 2009
- Developmental Programming: Contribution of Prenatal Androgen and Estrogen to Estradiol Feedback Systems and Periovulatory Hormonal Dynamics in Sheep1Biology of Reproduction, 2009
- Use of letrozole in assisted reproduction: a systematic review and meta-analysisHuman Reproduction Update, 2008
- Biotransformation of letrozole in rat liver microsomes: Effects of gender and tamoxifenJournal of Pharmaceutical and Biomedical Analysis, 2007
- Photoperiodic modulation of the dopaminergic control of pulsatile LH secretion in sheepJournal of Endocrinology, 1994
- Seasonal Changes in Gonadotropin-Releasing Hormone Secretion in the Ewe: Alteration in Response to the Negative Feedback Action of Estradiol1Biology of Reproduction, 1993